Direct Rx 2023-01-18 Health serious FDA
Health · FDA · Recall #FDA-D-0101-2023
Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By:… Recall
Issued January 18, 2023 · Direct Rx
In January 2023, Direct Rx recalled the Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By:…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP deviation: discontinue of stability support for product.
What you should do
- 1 Stop using Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Direct Rx to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Direct Rx
- Category
- Health
- Recall date
- January 18, 2023
- Units affected
- Not reported
- Sold at
- FL
- Recall number
- FDA-D-0101-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Direct Rx has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.